Joe Rogan Experience #2575 - Sam Tallent · Aired Nov 3, 2026
Claim summary · not a verbatim quotation
Sam Tallent said he quit drinking and then used Mounjaro, with his wife (a doctor) involved, as part of losing about 120 pounds.
The finding
What remains unresolved
Not a checkable claim: Sam Tallent said he quit drinking, then took Mounjaro (the transcript reads "Maro") with his wife, a doctor, closely involved, and lost about 120 pounds. Public sources confirm he is married to Dr. Emily Tallent, but the drug, the order of events and the amount lost are his own medical history, with no public record behind them. A public statement from him or his doctor giving different details would let this be checked.
No supporting source was captured. This finding should not be treated as a sourced conclusion.
Quick answer & review status
Quick answer
Is it true that Sam Tallent said he quit drinking and then used Mounjaro, with his wife (a doctor) involved, as part of losing about 120 pounds?
We can't say yet. Not a checkable claim: Sam Tallent said he quit drinking, then took Mounjaro (the transcript reads "Maro") with his wife, a doctor, closely involved, and lost about 120 pounds. Public sources confirm he is married to Dr. Sam Tallent said it (matched by voice) on Joe Rogan Experience #2575 - Sam Tallent, aired Nov 3, 2026, at 1:35:42. We couldn't settle it from the evidence we captured, so it stays an open question, not a false claim. No supporting source was captured, so don't treat this as a sourced conclusion.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.